The Role of Alpha Hemoglobin Stabilizing Protein in Human Beta Thalassemia

α 血红蛋白稳定蛋白在人类 β 地中海贫血中的作用

基本信息

  • 批准号:
    7565891
  • 负责人:
  • 金额:
    $ 41.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-01-19 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We are working toward a new perspective in understanding and manipulating the pathophysiology of ? thalassemia, a common and debilitating inherited anemia. A hallmark of this disorder is excessive free ? hemoglobin (Hb), an unstable protein that generates reactive oxygen species (ROS) and forms cytotoxic precipitates. We identified alpha hemoglobin stabilizing protein (AHSP), an abundant erythroid protein that enhances the solubility of free ?Hb and limits its biochemical reactivity. Ahsp-/- mice exhibit hemolytic anemia with Hb precipitates and excessive ROS. Moreover, loss of AHSP exacerbates ? thalassemia in mice, raising the possibility that altered AHSP function or expression could modulate ? thalassemia phenotypes in humans. Preliminary data support both mechanisms. First, we discovered a naturally occurring missense mutation, AHSP N75I, which impairs protein function and is associated with unexpectedly severe p thalassemia in two pedigrees. Second, AHSP appears to be a quantitative trait locus (QTL) whose expression varies considerably between different individuals. Moreover, reduced AHSP expression associates with more severe clinical disease in several independent studies of small p thalassemia cohorts and pedigrees. Together, these findings lead to the hypothesis that AHSP is a genetic modifier of ? thalassemia. We will test this by analyzing thalassemic populations for AHSP gene mutations, including N75I, and determining their effects on gene expression and/or protein function. In addition, we will study how variations in erythroid AHSP expression affect nascent ?Hb pools, oxidative stress and clinical severity in p thalassemic patients. Our findings should provide new insights into the mechanisms of normal erythropoiesis and the pathophysiology of ? thalassemia. Ultimately, this information could provide a basis for developing novel therapeutic approaches to mitigate the toxicities of free ?Hb in ? thalassemia.
描述(由申请人提供):我们正在努力理解和操纵病理生理学的新观点? Thalassyia,一种常见且令人衰弱的遗传性贫血。这种疾病的标志是免费的吗?血红蛋白(HB)是一种产生活性氧(ROS)并形成细胞毒性沉淀物的不稳定蛋白。我们确定了α血红蛋白稳定蛋白(AHSP),这是一种丰富的红斑蛋白,可增强游离?Hb的溶解度,并限制其生化反应性。 AHSP - / - 小鼠表现出溶血性贫血,Hb沉淀和过度ROS。此外,AHSP的损失加剧了吗?小鼠的丘脑症,提高了改变AHSP功能或表达可能调节的可能性?人类的丘脑表型。初步数据支持这两种机制。首先,我们发现了一个天然存在的错义突变AHSP N75i,它会损害蛋白质功能,并与两个谱系中出乎意料的严重P talalsassia相关。其次,AHSP似乎是一个定量性状基因座(QTL),其表达在不同个体之间的变化很大。此外,在小型p thalassemia cohorts and Gedigrees的几项独立研究中,AHSP表达与更严重的临床疾病相关。总之,这些发现导致了AHSP是遗传修饰符的假设?地中海贫血。我们将通过分析包括N75i在内的AHSP基因突变的丘脑血症种群来测试这一点,并确定其对基因表达和/或蛋白质功能的影响。此外,我们将研究红斑AHSP表达的变化如何影响p thalassmic患者的氧化应激,氧化应激和临床严重程度。我们的发现应该提供有关正常红血病机制和病理生理学机制的新见解?地中海贫血。最终,这些信息可以为开发新型的治疗方法提供基础来减轻自由?HB的毒性?地中海贫血。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mitchell J Weiss其他文献

Hematopoietic Stem Cells Supporting Fetal Erythropoiesis Are Differentially Regulated By Small and Large Ribosomal Subunits
  • DOI:
    10.1182/blood-2024-210699
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Yuefeng Tang;Te Ling;Rashid Mehmood;Mushran Khan;Julien Papoin;James Palis;Laurie A. Steiner;Sébastien Durand;Leonard I. Zon;Senthil Velan Bhoopalan;Mitchell J Weiss;Jeffrey Michael Lipton;Naomi Taylor;Patrick G. Gallagher;Mohandas Narla;John D. Crispino;Lionel Blanc
  • 通讯作者:
    Lionel Blanc
Adenine Base Editing Improves Erythropoiesis in Diamond-Blackfan Anemia Syndrome Patient-Derived Induced Pluripotent Stem Cells
  • DOI:
    10.1182/blood-2024-209312
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Shruthi Suryaprakash;Lei Han;Garret Manquen;Varun Katta;Damian Krzyzanowski;Jayaram Prasad;Nikitha Nimmagada;Kalin Mayberry;Nana Liu;Yan Ju;Yu Yao;Kelsey Ray;Marcin Wlodarski;Shengdar Q Tsai;Jonathan S Yen;Mitchell J Weiss;Senthil Velan Bhoopalan
  • 通讯作者:
    Senthil Velan Bhoopalan
Testing Rapamycin As an Anti-Adhesion Therapy for Sickle Cell Disease
  • DOI:
    10.1182/blood-2024-212384
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Danitza Nebor;Mitchell J Weiss;Jonathan M. Flanagan
  • 通讯作者:
    Jonathan M. Flanagan
miRNA-144/451 Regulates Cell Surface TfR1 Expression in Normal and β-Thalassemic Erythroblasts
  • DOI:
    10.1182/blood-2024-210302
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Georgios E. Christakopoulos;Alfonso G. Fernandez;Yu Yao;Rahul Telange;Dudley W. Michael;Tomas Ganz;Elizabeta Nemeth;Mitchell J Weiss
  • 通讯作者:
    Mitchell J Weiss
Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease
  • DOI:
    10.1182/blood-2024-200330
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Alexis Kristine Leonard;Akshay Sharma;Yogindra Persaud;Parul Rai;Darla Pickett;Renee Massey;Neha Das Gupta;Subodh Selukar;Salem M. Akel;Leigh Poston;Yan Zheng;Ella Sorani;Irit Gliko Kabir;Mitchell J Weiss;Stephen Gottschalk;Julie Kanter;Matthew Hsieh;John Tisdale
  • 通讯作者:
    John Tisdale

Mitchell J Weiss的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mitchell J Weiss', 18)}}的其他基金

ULK-mediated autophagy of α-globin in ß-thalassemia
α-地中海贫血中 ULK 介导的 α-珠蛋白自噬
  • 批准号:
    10649565
  • 财政年份:
    2022
  • 资助金额:
    $ 41.13万
  • 项目类别:
ULK-mediated autophagy of α-globin in ß-thalassemia
α-地中海贫血中 ULK 介导的 α-珠蛋白自噬
  • 批准号:
    10539754
  • 财政年份:
    2022
  • 资助金额:
    $ 41.13万
  • 项目类别:
Core B: Human Stem Cell Core
核心B:人类干细胞核心
  • 批准号:
    8698736
  • 财政年份:
    2014
  • 资助金额:
    $ 41.13万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    9242002
  • 财政年份:
    2014
  • 资助金额:
    $ 41.13万
  • 项目类别:
Regulation of erythropoiesis by the miR-144/451 microRNA locus
miR-144/451 microRNA 位点对红细胞生成的调节
  • 批准号:
    8726379
  • 财政年份:
    2014
  • 资助金额:
    $ 41.13万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    9025774
  • 财政年份:
    2014
  • 资助金额:
    $ 41.13万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    8843634
  • 财政年份:
    2014
  • 资助金额:
    $ 41.13万
  • 项目类别:
Regulation of erythropoiesis by the miR-144/451 microRNA locus
miR-144/451 microRNA 位点对红细胞生成的调节
  • 批准号:
    8868445
  • 财政年份:
    2014
  • 资助金额:
    $ 41.13万
  • 项目类别:
Trim58 and the Ubiquitin Proteasome System in Erythro-megakaryopoiesis
Trim58 和红细胞巨核细胞生成中的泛素蛋白酶体系统
  • 批准号:
    8819535
  • 财政年份:
    2014
  • 资助金额:
    $ 41.13万
  • 项目类别:
Regulation of erythropoiesis by the miR-144/451 microRNA locus
miR-144/451 microRNA 位点对红细胞生成的调节
  • 批准号:
    8546340
  • 财政年份:
    2012
  • 资助金额:
    $ 41.13万
  • 项目类别:

相似海外基金

Iron homeostasis and monocyte differentiation in patients with chronic kidney disease
慢性肾病患者的铁稳态和单核细胞分化
  • 批准号:
    10648527
  • 财政年份:
    2023
  • 资助金额:
    $ 41.13万
  • 项目类别:
A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease
一种与模态无关的效力测定,可实现镰状细胞病的体外和体内基因组编辑治疗
  • 批准号:
    10668694
  • 财政年份:
    2023
  • 资助金额:
    $ 41.13万
  • 项目类别:
Deciphering unintended large gene modifications in gene editing for sickle cell disease
破译镰状细胞病基因编辑中意外的大基因修饰
  • 批准号:
    10720685
  • 财政年份:
    2023
  • 资助金额:
    $ 41.13万
  • 项目类别:
Precision Apheresis: stem cell isolation from patients with sickle cell disease for gene therapy using high-throughput microfluidics
精密血浆分离术:使用高通量微流控技术从镰状细胞病患者中分离干细胞进行基因治疗
  • 批准号:
    10723247
  • 财政年份:
    2023
  • 资助金额:
    $ 41.13万
  • 项目类别:
Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD
CKD 中铁蛋白重链对巨噬细胞表型的调节
  • 批准号:
    10562610
  • 财政年份:
    2023
  • 资助金额:
    $ 41.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了